About a year ago, I first published my "weed investors' bible," The Roadmap to Marijuana Millions. At the time, it was packed with 30 of my absolute favorite plays in the still-booming legal cannabis sector.
Since then, weed investing's only gotten bigger, better, and more profitable.
Over the past year, this section of the Nova-X Report portfolio has seen 10 double-digit winners and eight triple-digit winners… 291% gains… 193.3%… 189.5%; one recommendation even saw peak gains of 1,588%.
In other words, if you're a subscriber who jumped in when I released a recommendation, you've likely made a mint… and you've probably kept a mint, too, if you closely follow my recommended "free trade" strategy of taking your initial stake off the table and playing with the "house money" every time a stock hands out 100% gains.
Normally, I keep these high-profit recommendations close to the vest, for my paid-up Nova-X Report readers, but several times throughout 2017, the profit potential has been so juicy that I've released recommendations for Money Morning Members to participate in, too.
Now I want to let everyone in on what's coming just around the corner.
I'm expecting four watershed events in marijuana investing to happen over the next 365 days.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.